ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.

David J Gallagher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.